Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain

References

Page 1

	Year	Citations
AETIOLOGY OF PARKINSON'S DISEASE DonaldB. Calne, J. William Langston The Lancet Neurological DisorderParkinson DiseaseDegenerative DiseaseNeuroscienceNeurology	1983	465
Low platelet monoamine oxidase activity in cigarette smokers Lars Oreland, Christopher J. Fowler, Daisy Schalling Life Sciences Tobacco ControlThrombosisTobacco UseAddictionMedicine	1981	128
Irreversible inhibition of monoamine oxidase by some components of cigarette smoke P. H. Yu, A. A. Boulton Life Sciences Tobacco ControlPsychoactive DrugBiochemistryIrreversible InhibitionAddiction	1987	122
Cigarette smoke impairs endothelial cell prostacyclin production. J.H. Reinders, Herm Jan M. Brinkman, Jan A. van Mourik, Arteriosclerosis An Official Journal of the American Heart Association Inc Vascular DiseaseEndothelial CellsImmunologyArachidonate MobilizationCellular Physiology	1986	86
An improved fluorimetric assay for brain monoamine oxidase Alun Morinan, Helen M. Garratt Journal of Pharmacological Methods NeurophysiologyBioanalysisNeuropharmacologyNeurochemical BiomarkersBrain Monoamine Oxidase	1985	72
Platelet monoamine oxidase: Low activity in cigarette smokers Trevor R. Norman, Kevin G. Chamberlain, Margaret A. French Psychiatry Research ThrombosisTobacco ControlTobacco UseAddictionMedicine	1987	69
Simultaneous mainstream-sidestream smoke exposure systems II. The rat exposure system R.B. Griffith, S. Standafer Toxicology Tobacco ControlAllergyRespiratory ToxicologyNicotineEnvironmental Health	1985	67
Monoamine oxidase B, smoking, and Parkinson's disease V. Wee Yong, Thomas L. Perry Journal of the Neurological Sciences Monoamine Oxidase BPsychoactive DrugAddictionParkinson DiseasePsychopharmacology	1986	60
Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke Laurence A. Carr, P. Rowell Neuropharmacology Tobacco ControlTobacco SmokeMedicineNicotineToxicology	1990	58
Chronic nicotine treatment partly protects against the 1‐methyl‐4‐phenyl‐2, 3, 6‐tetrahydropyridine‐induced degeneration of nigrostriatal dopamine neurons in the black mouse A. M. Janson, Kjell Fuxé, Erik Sundström, Acta Physiologica Scandinavica Nigrostriatal Dopamine NeuronsBlack MouseNeurophysiologyMedicineNicotine	1988	56

Page 1